Renal cell carcinoma deep sequencing: recent developments (Q38005625)

26 August 2017

Renal cell carcinoma deep sequencing: recent developments (English)

1 reference

26 August 2017

1 reference

Bin Tean Teh

3

0 references

author name string

Leslie J Farber

series ordinal

1

1 reference

PubMed ID

22535504

26 August 2017

Kyle Furge

series ordinal

2

1 reference

26 August 2017

1 June 2012

1 reference

26 August 2017

Current Oncology Reports

1 reference

26 August 2017

14

1 reference

26 August 2017

3

1 reference

26 August 2017

240-248

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-012-0230-3

26 August 2017

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Identification of the von Hippel-Lindau disease tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Senescence triggered by the loss of the VHL tumor suppressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Mutations in JARID1C are associated with X-linked mental retardation, short stature and hyperreflexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

A novel nonsense mutation in KDM5C/JARID1C gene causing intellectual disability, short stature and speech delay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Integrative genomic analyses of sporadic clear cell renal cell carcinoma define disease subtypes and potential new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

The Heidelberg classification of renal cell tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Hereditary Renal-Cell Carcinoma Associated with a Chromosomal Translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

A molecular classification of papillary renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Increased risk of cancer in patients with fumarate hydratase germline mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Molecular classification of renal tumors by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Expression profiling of human renal carcinomas with functional taxonomic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Microarray gene expression profiling and analysis in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Overexpression of KIT in chromophobe renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Differential gene expression identifies subgroups of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity: molecular and histologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Gene expression profiling predicts survival in conventional renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Improved prognostication of renal cell carcinoma using an integrated staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Initiating oncogenic event determines gene-expression patterns of human breast cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Gene expression phenotypic models that predict the activity of oncogenic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

PAGE: parametric analysis of gene set enrichment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Conventional renal cancer in a patient with fumarate hydratase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Expression of p270(ARID1A), a component of human SWI/SNF complexes, in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-012-0230-3

Prognostic implications of cytogenetic findings in kidney cancer

21 January 2018

1 reference

12 December 2020

The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.

1 reference

12 December 2020

Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas

1 reference

12 December 2020

Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array

1 reference

12 December 2020

Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.

1 reference

12 December 2020

Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors

1 reference

12 December 2020

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria

1 reference

12 December 2020

Cytogenetic analysis of 11 renal oncocytomas: further evidence of structural rearrangements of 11q13 as a characteristic chromosomal anomaly

1 reference

12 December 2020

A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD)

1 reference

12 December 2020

S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma

1 reference

12 December 2020

Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases

1 reference

12 December 2020

Differential gene expression in renal-cell cancer

1 reference

12 December 2020

Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas

1 reference

12 December 2020

Expression of S-100 protein in renal cell neoplasms

1 reference

12 December 2020

Combining differential expression, chromosomal and pathway analyses for the molecular characterization of renal cell carcinoma

1 reference

12 December 2020

The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma

1 reference

12 December 2020

Translocation t(3;8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14(FRA3B) in lymphocytes

1 reference

12 December 2020

Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors

1 reference

12 December 2020

A gene from human chromosomal band 3p21.1 encodes a highly conserved arginine-rich protein and is mutated in renal cell carcinomas

1 reference

12 December 2020

von Hippel-Lindau disease

1 reference

12 December 2020

Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma

1 reference

12 December 2020

Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases

1 reference

12 December 2020

Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis

1 reference

12 December 2020

Genetic alterations in metastatic renal cell carcinoma detected by comparative genomic hybridization: correlation with clinical and histological data

1 reference

12 December 2020

Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival

1 reference

12 December 2020

Recurrent genomic rearrangements are not at the fragile sites on chromosomes 3 and 5 in human renal cell carcinomas

1 reference

12 December 2020

Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma

1 reference

12 December 2020

Gene signatures of progression and metastasis in renal cell cancer

1 reference

12 December 2020

An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.

1 reference

12 December 2020

Loss of common 3p14 fragile site expression in renal cell carcinoma with deletion breakpoint at 3p14

1 reference

12 December 2020

Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1

1 reference

12 December 2020

Allelic loss of 3p25 associated with alterations of 5q22.3 approximately q23.2 may affect the prognosis of conventional renal cell carcinoma

1 reference

12 December 2020

Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma.

1 reference

12 December 2020

Alteration of mitochondrial DNA in human oncocytomas

1 reference

12 December 2020

High incidence of chromosome 1 abnormalities in a series of 27 renal oncocytomas: cytogenetic and fluorescence in situ hybridization studies

1 reference

12 December 2020

Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification

1 reference

12 December 2020

Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas

1 reference

12 December 2020

10.1007/S11912-012-0230-3

Identifiers

DOI

1 reference

PubMed ID

22535504

Dimensions Publication ID

26 August 2017

0 references

1 reference

PubMed ID

22535504